Ravindra L. Bakal

Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies

Pravin Shende, Ram Gaud, Ravindra L. Bakal et al. · Colloids and Surfaces B Biointerfaces · 2015 · 115 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Morphology, phytochemistry and pharmacological aspects of Carica papaya, an review

Ashish B. Wadekar, Minakshee G. Nimbalwar, Wrushali A. Panchale et al. · GSC Biological and Pharmaceutical Sciences · 2021 · 47 citations · Full text

Life Sciences, Botany, Pharmacology +16

QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads

Rahul D. Jawarkar, Praveen Sharma, Neetesh Kumar Jain et al. · Molecules · 2022 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Nitric Oxide and the Gastrointestinal Tract

Nitin I. Kochar, Anil V. Chandewal, Ravindra L. Bakal et al. · International Journal of Pharmacology · 2010 · 39 citations

Life Sciences, Internal Medicine, Physiology +12

RETRACTED: Repurposing food molecules as a potential BACE1 inhibitor for Alzheimer’s disease

Nobendu Mukerjee, Anubhab Das, Rahul D. Jawarkar et al. · Frontiers in Aging Neuroscience · 2022 · 30 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17